Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
Johnson & Johnson(JNJ) stock is priced at $245.30, giving the company a market capitalization of 577.44B. It carries a P/E multiple of 21.72 and pays a dividend yield of 2.2%.
On 2026-03-06, Johnson & Johnson(JNJ) shares started trading at $241.54, with intraday highs of — and lows of —.
Trading volume for Johnson & Johnson(JNJ) stock has reached 0, versus its average volume of 9.21M.
The stock's 52-week range extends from a low of $141.50 to a high of $251.71.
The stock's 52-week range extends from a low of $141.50 to a high of $251.71.
JNJ News
The latest announcement is out from Contineum Therapeutics, Inc. Class A ( (CTNM) ). Contineum Therapeutics amended its existing at-the-market equity program w...
Johnson & Johnson announced that the U.S. Food and Drug Administration approved Tecvayli plus Darzalex Faspro for the treatment of adults with relapsed or refra...
If you are wondering whether Johnson & Johnson is trading at a fair price today, you are not alone. The mix of a strong brand and changing headlines has many in...
Analyst ratings
57%
of 28 ratingsMore JNJ News
Investors in Johnson & Johnson (Symbol: JNJ) saw new options begin trading today, for the April 24th expiration. At Stock Options Channel , our YieldBoost formu...
JPMorgan raised the firm’s price target on Johnson & Johnson to $250 from $225 and keeps a Neutral rating on the shares. The firm cites its increased Tremfya es...
Johnson & Johnson recently announced that the U.S. FDA granted Fast Track designation to nipocalimab as a potential treatment for adults with systemic lupus ery...
Top 3 Dividend Aristocrat Stocks to Buy for Strong Returns in 2026 Quick Read Exxon Mobil (XOM) is up 26% year-to-date and Johnson & Johnson (JNJ) surged 68% f...
The officers and directors of a company tend to have a unique inside view into the business, so when these insiders make purchases, investors are wise to take n...
Johnson & Johnson JNJ is one of the key pharmaceutical players in the oncology segment, with its Oncology segment comprising around 27% of total revenues and 42...
Johnson & Johnson (JNJ) is back in focus after releasing preliminary Phase 1b data on pasritamig plus docetaxel in metastatic castration-resistant prostate canc...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.